Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.

Saved in:
Bibliographic Details
Title: Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.
Authors: Agiro A; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com., Greatsinger A; Analysis Group, Inc., 151 W 42nd Street, 23rd Floor, New York, NY, 10036, USA., Mu F; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Cook EE; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Chen J; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Sundar M; Analysis Group, Inc., 333 S Hope St # 27, Los Angeles, CA, 90071, USA., Zhao A; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Colman E; AstraZeneca, 121 Seaport Blvd, Boston, MA, 02210, USA., Malhotra A; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
Source: Advances in therapy [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 3960-3977. Date of Electronic Publication: 2025 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first